StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
9954.KL$0.20+2.56%
Fair $0.20+0.0%

9954.KL

RGT Berhad

Basic Materials / Specialty ChemicalsKuala Lumpur

$0.20

+0.01 (+2.56%)

Fairly Valued+0.0%Fair Value $0.20Fund rank 24/100 · Data gapFallback financials|
SA 27/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-6.7M · quality 43.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

27/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -1.1%, below the 5% threshold
Thesis & Journal · 9954.KLLocal privado en este navegador · RGT Berhad
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$68M

P/E

N/A

•

EV/EBITDA

11.5x

↑

ROE

-1.1%

↓

Gross Margin

17.6%

↓

Debt/Equity

0.50

↑
52-Week Range$0
$0$0

TradingView lightweight chart

9954.KL price, volumen y niveles de valoración

Último $0.200Periodo -77.2%
Fair value: $0.200

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.0%

FCF CAGR

—

FCF margin

-7.9%

FCF / Net income

6.82x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $140.3M · net income $-1.6M · FCF $-11.0M

2022-FY → 2025-FY

Gross margin

17.6%-8.0% pts

Operating margin

-0.6%-11.9% pts

Net margin

-1.2%-9.4% pts

FCF margin

-7.9%+21.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$140.3M$140.3M$110.4M$107.3M$121.2M
Net Income$-1.6M$-1.6M$5.3M$1.8M$10.0M
EBITDA$10.6M$10.6M$16.5M$16.1M$21.2M
EPS-0.00-0.001.510.010.03
Gross Margin17.6%17.6%19.4%22.5%25.6%
Operating Margin-0.6%-0.6%-1.4%4.4%11.3%
Net Margin-1.2%-1.2%4.8%1.6%8.2%
Balance Sheet
Debt/Equity0.500.500.410.400.42
Current Ratio1.491.49———
Cash Flow
Free Cash Flow$-11.0M$-11.0M$-1.1M$-6.7M$-35.4M
Returns
ROE-1.1%-1.1%3.6%1.2%7.2%
Valuation
P/E——0.5549.069.91
EV/EBITDA11.4811.4819.897.096.15
P/B0.480.481.960.570.71
Growth & Yield
Revenue Growth27.1%27.1%2.9%-11.5%—
EPS Growth-100.3%-100.3%28390.6%-84.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -52.4%

Total return

-52.4%

Start / end P/E

n/dx → n/dx

EPS bridge

1.51 → -0.00

Residual

-52.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-52.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.